The Lancet publishes the phased results of the Sichuan University drug weight loss clinical research

On December 9, 2021, The Lancet, one of the "Four Major Journals of Clinical Medicine", published online the phased results of a clinical study on weight loss with drugs in West China Hospital of Sichuan University.

Shi Qingyang, research assistant in the Evidence-Based Evaluation and Quick Guide Laboratory of China Evidence-Based Medicine Center, West China Hospital, Sichuan University, and Wang Yang, a 2021 professional master's student in the Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, are the co-first authors of the paper, and the Department of Endocrinology and Metabolism, West China Hospital, Sichuan University /Associate Professor Li Sheyu, Evidence-based Evaluation and Quick Guide Research Office, China Evidence-Based Medicine Center, is the corresponding author, and West China Hospital of Sichuan University is the only first author and corresponding author unit

Obesity is an important risk factor for endocrine metabolism and cardiovascular diseases, and has long been at the forefront of disease burden

Invited by the editorial office of Lancet, Professor CW le Roux, University College Dublin, Ireland, highly praised the impact of this research on clinical practice

Article link:

https://